Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial. - Wikidata - awgldk - TriplyDB

Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial.

Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial.

http://www.wikidata.org/entity/Q44915194

about

Atypical antipsychotics in bipolar disorder: systematic review of randomised trials Risperidone alone or in combination for acute mania Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm Differences in efficacy and safety of pharmaceutical treatments between men and women: an umbrella review Current and emerging therapies for the management of bipolar disorders Bipolar disorder.Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis The psychopathology and treatment of bipolar disorder.Long-acting risperidone: a review of its role in the treatment of bipolar disorder.Use pattern and off-label use of atypical antipsychotics in bipolar disorder, 1998-2002 Disease and drug effects on internally-generated and externally-elicited responses in first episode schizophrenia and psychotic bipolar disorder.Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder.Endoxifen, a New Treatment Option for Mania: A Double-Blind, Active-Controlled Trial Demonstrates the Antimanic Efficacy of Endoxifen Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania.Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?Acute and long-term treatment of mania.Bipolar mixed states and their treatment.Risperidone for bipolar disorders.Atypical antipsychotics: newer options for mania and maintenance therapy.Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder.Higher than Physician's Desk Reference (US) doses on atypical antipsychotics.Economic outcomes associated with atypical antipsychotics in bipolar disorder: a systematic review.Anticonvulsants in the treatment of bipolar mania.Risperidone treatment of bipolar mania.Treatment of aggression with risperidone in children and adolescents with bipolar disorder: a case series.Emerging drugs for bipolar disorder.Risperidone versus risperidone plus sodium valproate for treatment of bipolar disorders: a randomized, double-blind clinical-trial Depot antipsychotic medications in bipolar disorder: a review of the literature.Adjunctive treatment of acute mania: a clinical overview.Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials.Prescription patterns of psychotropic medications in elderly compared with younger participants who achieved a "recovered" status in the systematic treatment enhancement program for bipolar disorder Comparison of mania patients suitable for treatment trials versus clinical treatment Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review.Risperidone in the treatment of bipolar mania.Safety of carbamazepine extended-release capsules used in combination with other psychotropic medications for the treatment of bipolar I disorder.A UK consensus on the administration of aripiprazole for the treatment of mania.Treating bipolar disorder in the primary care setting: the role of aripiprazole.Advancing bipolar disorder: key lessons from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

P2860

Q21260276-61768891-A4BA-49F7-BB9E-ADC7B83D7988 Q24244719-03A9F64F-A2BD-48E4-B228-EA2EA660750C Q24601815-41226B5B-EEB0-4269-9F4B-E0B81A561234 Q28066714-65C3FDC5-14C7-495A-BC87-A7966AE7BC1F Q28474985-A46D3E2A-02BD-4AD4-BF71-D49EB866D650 Q28686902-EA3942B8-5124-4694-8288-7ABFE874695B Q33448290-83FBC396-2D06-4D93-8DCB-58C6D1F64361 Q33529314-ED289B18-4069-4389-A610-1BF2AEF5CCBE Q33619910-4E55267C-86B3-4C00-B456-C42C84EF7A38 Q33886093-F478E86E-54C9-4FFB-8ED7-AED15303C04F Q33932148-519233BC-EECF-495F-A320-A21A44FC384F Q34254441-B7626241-611C-4FDF-878E-6DB5C1A1385F Q34455825-6C0A0373-7A97-40BB-A464-4DFFCC82E362 Q34532071-BB529DC9-BA43-4353-B796-ADBD7F8CD90D Q34595255-E12CCB7F-5A7D-4D65-8ACA-754BE11A0BB5 Q34606256-2718FF69-089D-498F-B031-91202CFCE9A2 Q34809427-993BAAEF-9998-4E13-9AD9-9232059F07E8 Q35236966-30AF6CAA-E35C-41EA-94A9-BAB7E9D7B0D4 Q36106765-B2EB070B-CBCC-4F62-94EF-A41C4F98EE4E Q36106798-F9A55DA1-9116-4322-A963-3F6C9E3591BB Q36158824-1851438D-CB82-4356-BC23-411B4B294E83 Q36162402-1CEAB288-ECAE-4F4D-BAC4-4CD5C4414E9E Q36191013-4C90782F-DBB0-4332-A07A-A5093B3B0595 Q36274272-41F85A73-8593-4076-9216-511C0B5B47F2 Q36407359-89AD42A1-C73D-4F7A-89CA-4E6E0C94AD35 Q36434309-62863E9F-2DD8-4D3A-80D3-EF9CE838D446 Q36551909-BADB4F78-D213-4A08-9E38-B4F69B3C57AB Q36634257-78C15A2F-99D0-4E18-8220-82252AB2CEDC Q36780394-04635E69-9A16-412F-BC57-9B5A2471DEE0 Q36905876-ED8E7EA5-5AF7-4F7A-B803-CC112C6C2558 Q36905879-B1709B58-CDB0-424A-95AC-AE8508B5898C Q36936379-22016C4D-EF80-4830-8D36-5996B3AA2CDC Q37070490-3C203E87-3CC4-4B49-A485-271F33D30BD6 Q37100104-910A6ACC-546A-4624-B8E0-30ACFC66EC85 Q37111491-57D2F096-6222-47D4-966E-493EF23C1444 Q37165588-68AFF0C3-788C-4AF3-82AF-F01D795DDC1C Q37202889-CFF8BB6E-57C2-4C32-9DEA-8CD5D5C28C9E Q37326130-5D67024C-F7CC-4DCE-BF41-091EF1C7C6AE Q37429721-3E30EE6C-1EBD-4307-84BD-5CED0F9DF9CF Q37725149-B26E0609-1A13-4CD5-8E02-F2A813E76606

P2860

Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial.

http://www.wikidata.org/entity/Q44915194

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Rapid antimanic effect of risp ...... ind, placebo-controlled trial.

@en

Rapid antimanic effect of risp ...... ind, placebo-controlled trial.

@nl

type

label

Rapid antimanic effect of risp ...... ind, placebo-controlled trial.

@en

Rapid antimanic effect of risp ...... ind, placebo-controlled trial.

@nl

prefLabel

Rapid antimanic effect of risp ...... ind, placebo-controlled trial.

@en

Rapid antimanic effect of risp ...... ind, placebo-controlled trial.

@nl

P1433

Q44915194-583DC8FC-A332-44BA-BC95-924E9889A001

P1476

Q44915194-4E1EF85A-2A56-4BCB-A51B-BE91499DFF1B

P2093

Q44915194-16CCB186-D9C7-4179-AE36-383FFC39A92B

Q44915194-55A60B06-429D-4798-B891-B1D1CC7DDF1E

Q44915194-66EF79A4-FE62-4213-8095-6FFCF670F794

Q44915194-68EAA284-486B-427C-95D0-BBB3DDADCC08

Q44915194-81DCE932-F291-4BB4-88CF-F6BC5BD9893C

Q44915194-C217347F-1F7C-40E6-82AB-A5EF552F49C6

Q44915194-CA2FB359-AD09-4B2D-80DF-32B34DA4EC06

P304

Q44915194-CC8A780E-F4B4-4017-9FAA-309326D571B3

P31

Q44915194-3267FEE5-AA74-4966-A15D-1EA6AD691E59

P356

Q44915194-C570A237-66A4-4C71-955D-8FFA4CE84B92

P407

Q44915194-5A34F37C-C402-4A54-9E46-FBD46DE66FFD

P433

Q44915194-1A203F4D-C7AC-486E-9E58-070785554D1B

P478

Q44915194-F6D8F13A-1E86-4229-B82C-76DBADD25D9C

P577

Q44915194-05FAD6A9-7D5D-47CA-AB93-AD97743BC141

P5875

Q44915194-6369E7F0-9520-4122-B598-DD8EB5563F10

P698

Q44915194-6187D596-D02C-4515-884B-12214CE12820

P921

Q44915194-AB0C5FB8-E966-40A8-92CD-D3D4E80DAE24

P356

APPI.AJP.161.6.1057

P1433

American Journal of Psychiatry

P1476

Rapid antimanic effect of risp ...... ind, placebo-controlled trial.

@en

P2093

Carla Canuso

http://www.w3.org/2001/XMLSchema#string

Fred Grossman

http://www.w3.org/2001/XMLSchema#string

Keith Karcher

http://www.w3.org/2001/XMLSchema#string

Marielle Eerdekens

http://www.w3.org/2001/XMLSchema#string

Michelle Kramer

http://www.w3.org/2001/XMLSchema#string

Paul E Keck

http://www.w3.org/2001/XMLSchema#string

Robert M A Hirschfeld

http://www.w3.org/2001/XMLSchema#string

P304

1057-1065

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1176/APPI.AJP.161.6.1057

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

161

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8536418

http://www.w3.org/2001/XMLSchema#string

P698

15169694

http://www.w3.org/2001/XMLSchema#string

P921